KYM‐001, A FIRST‐IN‐CLASS ORAL IRAK4 PROTEIN DEGRADER, INDUCES TUMOR REGRESSION IN XENOGRAFT MODELS OF MYD88‐MUTANT ABC DLBCL ALONE AND IN COMBINATION WITH BTK INHIBITION.

Autor:	Kelleher, J., Campbell, V., Chen, J., Gollob, J., Ji, N., Kamadurai, H., Klaus, C., Li, H., Loh, C., McDonald, A., Rong, H., Rusin, S., Sharma, K., Vigil, D., Walker, D., Weiss, M., Yuan, K., Zhang, Y., Mainolfi, N.
Předmět:	REGRESSION analysis STOCK ownership ONCOLOGY APOPTOSIS inhibition TUMORS
Zdroj:	Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p129-129, 1p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text